消除黑人婴儿胆红素脑病的隐性健康差异:综述
本综述指出,美国黑人新生儿约占全部新生儿的14%,却占胆红素脑病病例的25%以上,构成被忽视的健康差异。尽管黑人新生儿临床显著高胆红素血症的总体发生率较低,但存在此前未被认识的危险性高胆红素血症风险,这一矛盾可解释该差异。综述汇总了生物学与非生物学影响因素,并提出家长层面与临床医生层面的预防策略以减少该差异。
要点
- 黑人新生儿占美国胆红素脑病病例25%以上,但仅占全部新生儿约14%。
- 黑人新生儿临床显著高胆红素血症总体发生率较低,但存在危险性高胆红素血症的未识别风险。
- 预防策略包括提升家长对新生儿黄疸和急性胆红素脑病的健康素养,以及加强临床医生对危险因素的认知和胆红素监测。
核心结论
- 黑人婴儿胆红素脑病风险存在 multiple 可干预的机会,尽管该病罕见,但黑人婴儿中的发生率及预防工作均不可忽视。
研究设计与样本
- 本综述基于文献汇总,分析黑人婴儿胆红素脑病健康差异的生物学与非生物学 Contributing 因素及预防策略。
主要发现
- 美国黑人新生儿占胆红素脑病病例25%以上,但仅占全部新生儿约14%。
- 黑人新生儿临床显著高胆红素血症总体发生率较低,但存在此前未被认识的危险性高胆红素血症风险,构成 paradox。
临床怎么用
- 家长层面:提升对新生儿黄疸和急性胆红素脑病的健康素养,并促进其因黄疸主动就医。
- 临床医生层面:消除阻碍就医的社区和机构障碍,提高对黑人婴儿胆红素脑病危险因素的认知,加强新生儿高胆红素血症管理和胆红素监测。
局限性
- 胆红素脑病为罕见病,需持续研究以了解其当前范围和黑人新生儿中的发生情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Kernicterus is a devastating, permanently disabling neurologic condition resulting from bilirubin neurotoxicity. Black neonates account for more than 25% of kernicterus cases in the US, despite making up only approximately 14% of all births. This is a largely overlooked health disparity. OBSERVATIONS: The black kernicterus health disparity exists despite a lower overall incidence of clinically significant hyperbilirubinemia among black neonates, a paradox recently explained by a previously unrecognized risk for hazardous hyperbilirubinemia. Aligned with national and global health initiatives to reduce or eliminate health disparities, this review highlights the multiple biologic and nonbiologic factors contributing to kernicterus risk in black infants and approaches to reduce this health disparity. This includes both parent-level and clinician-level kernicterus prevention strategies, with an emphasis on improving parental health literacy on neonatal jaundice and acute bilirubin encephalopathy and clinician awareness of the key factors that contribute to hazardous hyperbilirubinemia risk in this vulnerable group. Parent-level prevention strategies include efforts to improve their health literacy on neonatal jaundice and acute bilirubin encephalopathy and empower care seeking for jaundice. Clinician-level prevention strategies include efforts to eliminate community and institutional barriers that impede access to care, heighten clinician awareness of the factors that contribute to kernicterus risk in this vulnerable patient group, and strengthen newborn hyperbilirubinemia management and bilirubin surveillance. CONCLUSIONS AND RELEVANCE: There are multiple opportunities for intervention to reduce black kernicterus risk. Although kernicterus is a rare disorder, the incidence among black infants is not a trivial matter nor are efforts to prevent kernicterus. While the multiple interacting biologic and nonbiologic contributors to increased kernicterus risk among black infants pose a considerable challenge to clinicians, there are opportunities for intervention to reduce this risk and health disparity. Continued study is imperative to understand the current scope of kernicterus and its occurrence in black neonates.
引用
- Okolie F, South-Paul JE, Watchko JF, et al. Combating the Hidden Health Disparity of Kernicterus in Black Infants: A Review. JAMA Pediatr. 2020. PMID: 32628268. doi:10.1001/jamapediatrics.2020.1767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。